Stem Cell Therapy for Macular Degeneration Perfected

British scientists have announced that they have perfected a stem cell therapy for macular degeneration that will reverse the eye disease.  Pioneered initially at the Institute of Ophthalmology at University College London and Moorfields eye hospital, the stem cell therapy involves replacing a layer of degenerated eye cells with embroyonic stem cells.

It is expected that Pfizer, one of the largest pharmaceutical companies will provide financial backing for the stem cell therapy for macular degeneration.  More information on this arrangement can be found at